Correspondence: First Peanut ( <i>Arachis hypogaea</i> ) Allergen Oral Immunotherapy Product Out of Sale—A Major Drawback for Food Allergy Immunotherapy?
Bundesministerium für Ernährung und Landwirtschaft
Hospital for Sick Children
European Academy of Allergy and Clinical Immunology
Bausch Health
Food Allergy Canada
Genentech
Novartis Pharma
Allergopharma
Canadian Institutes of Health Research
Medical Research Council
Instituto de Salud Carlos III
National Institute of Allergy and Infectious Diseases
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Correspondence: First Peanut ( Arachis hypogaea ) Allergen Oral Immunotherapy Product Out of Sale—A Major Drawback for Food Allergy Immunotherapy?
Aikaterini Anagnostou, Friederike Bärhold, Montserat Alvaro‐Lozano, Stefania Arasi et al.
Journal
Allergy
Topics
Food Allergy and Anaphylaxis Research
article
Correspondence: First Peanut ( Arachis hypogaea ) Allergen Oral Immunotherapy Product Out of Sale—A Major Drawback for Food Allergy Immunotherapy?
Aikaterini Anagnostou, Friederike Bärhold, Montserat Alvaro‐Lozano, Stefania Arasi, M. J. Torres, L. Klimek, A. Muraro, S. B. Sindher, K. Blumchen, S. Chinthrajah, A. Fiocchi, J. Upton, K. Beyer, P. Begin, T. Eiwegger, M. Shamji, M. Ebisawa
article en
Abstract
No abstract available for this paper.
Publication Tag
Allergy
Institutions
Goethe University Frankfurt (DE), Hospital Sant Joan de Déu Barcelona (ES), University of Padua (IT), Baylor College of Medicine (US), University of Toronto (CA), Allergy, Asthma and Clinical Research Center (US), Hospital Regional Universitario de Málaga (ES), NIHR Imperial Biomedical Research Centre (GB), Universitätsklinikum St. Pölten (AT), National Sagamihara Hospital (JP), Zentrum für Rhinologie und Allergologie (DE), Bambino Gesù Children's Hospital (IT), SickKids Foundation (CA), Texas Children's Hospital (US), Karl Landsteiner University of Health Sciences (AT), Instituto de Investigación Biomédica de Málaga (ES), Imperial College London (GB), Université de Montréal (CA), Charité - Universitätsmedizin Berlin (DE)
Funders
Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Danone, Regeneron Pharmaceuticals, Nestlé Health Science, Innovationsfonden, Immune Tolerance Network, Aimmune Therapeutics, Mylan, Allergy Therapeutics, Celltrion, European Commission, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Bundesministerium für Ernährung und Landwirtschaft, Hospital for Sick Children, European Academy of Allergy and Clinical Immunology, Bausch Health, Food Allergy Canada, Genentech, Novartis Pharma, Allergopharma, Canadian Institutes of Health Research, Medical Research Council, Instituto de Salud Carlos III, National Institute of Allergy and Infectious Diseases